NSE › Healthcare

Emcure Pharmaceuticals Ltd (EMCURE)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,969.70+0.49%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹2,470 cr
Revenue YoY
+21.7%
Net profit
₹243 cr
Profit YoY
+28.8%
EPS
₹14.70
EPS estimate
₹13.60
Net margin
9.9%

EPS came in at 14.70 against a street estimate of 13.60 — a beat of 8.1%.

Key statistics

Market cap
₹37,166 cr
P/E
40.1
Forward P/E
0.0
P/B
7.51
Book value
₹261.12
EPS (TTM)
₹48.81
Dividend yield
0.18%
52-week high
₹1,999.00
52-week low
₹1,260.00
50-day MA
₹1,800.69
200-day MA
₹1,575.62
Beta
-0.02

Analyst view

with an average price target of ₹1,963.00.

Shareholding

Promoters
81.70%
Institutions
5.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Emcure Pharmaceuticals Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.